Christopher P. Cannon

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.751Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp(a) Registry

Journal of the American Heart Association(2024)10.1161/jaha.123.034493

Top 27%

0.751DataRank

Top 27%26 citations

Adam N. Berman, Stephanie A. Besser, David Biery, Gurleen Kaur, Sanjay Divakaran +11 more

Papers

Driven by 19 papers — median percentile 73. Top paper: “Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease”.

Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease

JAMA(2020)10.1001/jama.2020.23649

N/A

3.7DataRank · unranked

130 citations

KyungMann Kim, Jacob A. Udell, Jacob Joseph, Akshay S. Desai, Michael E. Farkouh +22 more

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

Stroke(2021)10.1161/strokeaha.120.031623

N/A

3.6DataRank · unranked

120 citations

Meg Jardine, Qiang Li, Brendon L. Neuen, Christopher P. Cannon, Dick de Zeeuw +95 more

Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria

Clinical Journal of the American Society of Nephrology(2021)10.2215/cjn.15260920

N/A

3.4DataRank · unranked

54 citations

Zien Zhou, Hiddo J.L. Heerspink, Carinna Hockham, Qiang Li, Rajiv Agarwal +18 more

Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus

Diabetes Obesity and Metabolism(2022)10.1111/dom.14769

N/A

1.8DataRank · unranked

45 citations

Ahmed A. Kolkailah, Robert Frederich, Annpey Pong, Christopher P. Cannon, Francesco Cosentino +10 more

Cardiovascular and Renal Outcomes with Canagliflozin According to Baseline Diuretic Use: A Post Hoc Analysis from the CANVAS Program

ESC Heart Failure(2021)10.1002/ehf2.13236

N/A

0.967DataRank · unranked

23 citations

Clare Arnott, Brendon L. Neuen, Hiddo L. Heersprink, Kenneth W. Mahaffey, Christopher P. Cannon +11 more

Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp(a) Registry

Journal of the American Heart Association(2024)10.1161/jaha.123.034493

Top 27%

0.751DataRank

Top 27%26 citations

Adam N. Berman, Stephanie A. Besser, David Biery, Gurleen Kaur, Sanjay Divakaran +11 more

Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease

Circulation(2016)10.1161/circulationaha.115.018383

N/A

0.670DataRank · unranked

86 citations

Ken Williams, Kathleen Kimler Altobelli, Michael J. Pencina, Christopher P. Cannon, Allan D. Sniderman +1 more

Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial

Journal of the American Heart Association(2022)10.1161/jaha.121.025045

N/A

0.578DataRank · unranked

10 citations

Clare Arnott, Hiddo J.L. Heerspink, Qiang Li MBiostat, Christopher P. Cannon, David C. Wheeler +16 more

Risk markers of incident atrial fibrillation in patients with coronary heart disease

American Heart Journal(2021)10.1016/j.ahj.2020.12.016

N/A

0.442DataRank · unranked

18 citations

Claes Held, Nermin Hadziosmanovic, Johan Westerbergh, Johan Lindbäck, Philip E. Aylward +15 more

Time to Clinical Benefit with Sotagliflozin in Patients with Type 2 Diabetes and Chronic Kidney Disease: Insights from the SCORED Randomized Trial

European Journal of Heart Failure(2024)10.1002/ejhf.3240

N/A

0.241DataRank · unranked

4 citations

Deepak L. Bhatt, Michael Szarek, Lawrence A. Leiter, Christopher P. Cannon, Renato D. Lópes +5 more

Muscle Complaints or Events in Patients Randomized to Simvastatin or Ezetimibe/Simvastatin

Journal of the American College of Cardiology(2020)10.1016/j.jacc.2019.12.022

N/A

0.208DataRank · unranked

3 citations

Ann Marie Návar, Robert P. Giugliano, Jennifer A. White, Yuliya Lokhnygina, Yale Mitchel +4 more

A polygenic risk score predicts atrial fibrillation in cardiovascular disease

European Heart Journal(2022)10.1093/eurheartj/ehac460

N/A

0DataRank · unranked

82 citations

Amanda C. Garfinkel, Frederick Kamanu, Giorgio Melloni, Carolina Roselli, Petr Jarolı́m +15 more

Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry

Clinical Cardiology(2020)10.1002/clc.23376

N/A

0DataRank · unranked

20 citations

Thomas M. Maddox, Lucas Marzec, Benjamin A. Rodwin, Salim S. Virani, Amarnath Annapureddy +12 more

Contemporary Trends in Prescription of Dipeptidyl Peptidase-4 Inhibitors in the Context of US Food and Drug Administration Warnings of Heart Failure Risk

The American Journal of Cardiology(2020)10.1016/j.amjcard.2020.01.053

N/A

0DataRank · unranked

7 citations

Avinainder Singh, Abhinav Sharma, James L. Januzzi, Benjamin M. Scirica, Javed Butler +5 more

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice

Kidney International(2020)10.1016/j.kint.2020.10.042

N/A

0DataRank · unranked

160 citations

Meg Jardine, Rajiv Agarwal, George L. Bakris, Christopher P. Cannon, David M. Charytan +15 more

Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events

JACC Heart Failure(2023)10.1016/j.jchf.2023.05.026

N/A

0DataRank · unranked

46 citations

Deepak L. Bhatt, Michael Szarek, Christopher P. Cannon, Lawrence A. Leiter, Darren K. McGuire +17 more

Effects of Ertugliflozin on Kidney Outcomes in Patients With Heart Failure at Baseline in the Evaluation of Ertugliflozin Efficacy and Safety Cardiovascular Outcomes (VERTIS CV) Trial

Kidney International Reports(2023)10.1016/j.ekir.2023.01.011

N/A

0DataRank · unranked

1 citations

Francesco Cosentino, Darren K. McGuire, Ahmed A. Kolkailah, Samuel Dagogo‐Jack, Richard E. Pratley +5 more

Lipoprotein(a) as a cardiovascular risk factor among patients with and without diabetes Mellitus: the Mass General Brigham Lp(a) Registry

Cardiovascular Diabetology(2024)10.1186/s12933-024-02348-2

N/A

0DataRank · unranked

20 citations

Adam N. Berman, Stephanie A. Besser, David Biery, Rhanderson Cardoso, Sanjay Divakaran +11 more

Methods, rationale, and design for a remote pharmacist and navigator-driven disease management program to improve guideline-directed medical therapy in patients with type 2 diabetes at elevated cardiovascular and/or kidney risk

Primary care diabetes(2024)10.1016/j.pcd.2024.01.005

N/A

0DataRank · unranked

7 citations

Lee‐Shing Chang, Caitlin Colling, Gretchen Stern, Daniel Gabovitch, Guinevere Feldman +14 more

Christopher P. Cannon

Indexed papers

Top data-sharing exemplar

Papers